IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.170
-0.030 (-1.36%)
At close: Jul 18, 2025, 4:00 PM
2.250
+0.080 (3.69%)
After-hours: Jul 18, 2025, 5:50 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $7.47 million as of July 18, 2025. Its market cap has decreased by -79.17% in one year.
Market Cap
7.47M
Enterprise Value
30.19K
1-Year Change
-79.17%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $7.47M, a decrease of -96.01%. That is a compound annual growth rate of -55.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 17, 2025 | 7.58M | -59.36% |
Dec 31, 2024 | 18.64M | -68.76% |
Dec 29, 2023 | 59.67M | 5.43% |
Dec 30, 2022 | 56.60M | -31.25% |
Dec 31, 2021 | 82.33M | -56.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 704.72B |
Johnson & Johnson | 392.00B |
AbbVie | 335.14B |
Novo Nordisk | 301.36B |
UnitedHealth Group | 261.85B |
Novartis AG | 233.75B |
AstraZeneca | 217.77B |
Abbott Laboratories | 213.20B |